Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis.

Swede Helen; Helen Swede; Sarwar Amna; Amna Sarwar; Magge Anil; Anil Magge; Braithwaite Dejana; Dejana Braithwaite; Cook Linda S.; Linda S Cook; Gregorio David I.; David I Gregorio; Jones Beth A.; Beth A Jones; Hoag Jessica R.; Jessica R Hoag; Gonsalves Lou; Lou Gonsalves; Salner Andrew L.; Andrew L Salner; Zarfos Kristen; Kristen Zarfos; Andemariam Biree; Biree Andemariam; Stevens Richard G.; Richard G Stevens; Dugan Alicia G.; Alicia G Dugan; Pensa Mellisa; Mellisa Pensa; Brockmeyer Jessica A.; Jessica A Brockmeyer

首页> 外文期刊>Cancer causes and control: CCC >Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis.

【24h】

Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis.

机译：来自组合的死亡率风险独立于三阴性乳腺癌状态：基于NCI-Seer的队列分析。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

comorbidities at diagnosis increase risk of death independent of TNBC, and AA/B patients may be disproportionately at risk.

机译：诊断过程中的致病性增加了独立于TNBC的死亡风险，AA / B患者可能存在风险不成比例。

著录项

来源
《Cancer causes and control: CCC》 |2016年第5期|共10页
作者
Swede Helen; Helen Swede; Sarwar Amna; Amna Sarwar; Magge Anil; Anil Magge; Braithwaite Dejana; Dejana Braithwaite; Cook Linda S.; Linda S Cook; Gregorio David I.; David I Gregorio; Jones Beth A.; Beth A Jones; Hoag Jessica R.; Jessica R Hoag; Gonsalves Lou; Lou Gonsalves; Salner Andrew L.; Andrew L Salner; Zarfos Kristen; Kristen Zarfos; Andemariam Biree; Biree Andemariam; Stevens Richard G.; Richard G Stevens; Dugan Alicia G.; Alicia G Dugan; Pensa Mellisa; Mellisa Pensa; Brockmeyer Jessica A.; Jessica A Brockmeyer;
展开▼
作者单位

Univ Connecticut Sch Med Dept Community Med &

Hlth Care 263 Farmington Ave Farmington CT 06030;

Department of Community Medicine and Health Care University of Connecticut School of Medicine 263;

Univ Connecticut Sch Med Dept Community Med &

Hlth Care 263 Farmington Ave Farmington CT 06030;

Univ Connecticut Sch Med Dept Community Med &

Hlth Care 263 Farmington Ave Farmington CT 06030;

Univ Calif San Francisco Dept Epidemiol &

Biostat San Francisco CA 94143 USA;

Univ New Mexico Dept Epidemiol Biostat &

Prevent Med Albuquerque NM 87131 USA;

Univ Connecticut Sch Med Dept Community Med &

Hlth Care 263 Farmington Ave Farmington CT 06030;

Yale Univ Sch Publ Hlth New Haven CT USA;

Univ Connecticut Sch Med Dept Community Med &

Hlth Care 263 Farmington Ave Farmington CT 06030;

Connecticut Dept Publ Hlth Connecticut Tumor Registry Hartford CT USA;

Hartford Hosp Hartford HealthCare Syst Helen &

Harry Gray Canc Ctr Hartford CT USA;

Hosp Cent Connecticut Hartford HealthCare Syst Hartford CT USA;

Univ Connecticut Hlth Dept Med New England Sickle Cell Inst Farmington CT USA;

Univ Connecticut Sch Med Dept Community Med &

Hlth Care 263 Farmington Ave Farmington CT 06030;

Univ Connecticut Hlth Dept Med New England Sickle Cell Inst Farmington CT USA;

Yale Univ Sch Med Dept Occupat &

Environm Med New Haven CT USA;

Univ Connecticut Sch Med Dept Community Med &

Hlth Care 263 Farmington Ave Farmington CT 06030;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis. [J] . Swede Helen, Helen Swede, Sarwar Amna, Cancer causes and control: CCC . 2016,第5期

机译：独立于三阴性乳腺癌的合并症的死亡率风险：基于NCI-SEER的队列分析。
2. Cumulative Incidence of Non-breast Cancer Mortality and Breast Cancer Risk by Comorbidity and Age among Older Women Undergoing Screening Mammography: The Medicare-linked Breast Cancer Surveillance Consortium Cohort Study [J] . Demb J., Abraham L., Miglioretti D. L., Cancer epidemiology, biomarkers and prevention: A publication of the American Association for Cancer Research . 2018,第3期

机译：在接受筛查乳房X线照相术治疗乳房X线摄影术中的合并和年龄的非乳腺癌死亡率和乳腺癌风险的累积发病率：Medicare联系的乳腺癌监测联盟队列队列队列研究
3. Bisphosphonate Use and Risk of Recurrence, Second Primary Breast Cancer, and Breast Cancer Mortality in a Population-Based Cohort of Breast Cancer Patients [J] . Korde Larissa A., Doody David R., Hsu Li, Cancer epidemiology, biomarkers and prevention: A publication of the American Association for Cancer Research . 2018,第2期

机译：双膦酸盐使用和复发性，第二原发性乳腺癌和乳腺癌死亡率的危险，基于人群的乳腺癌患者
4. Inhalation Cancer Risk Assessment for Hexavalent Chromium: Painesville Cohort Mortality Study [C] . Deborah Proctor International electricity sector conference . 2015

机译：六价铬的吸入性癌症风险评估：Painesville队列死亡率研究
5. Associations between serum vitamin D, genetic polymorphisms in the vitamin D pathway, and sarcopenia with overall and breast cancer-specific mortality in a cohort of breast cancer survivors. [D] . Villasenor, Adriana. 2011

机译：人群中的血清维生素D，维生素D途径的遗传多态性和肌肉减少症与乳腺癌幸存者的总体死亡率和乳腺癌特异性死亡率之间的关联。
6. Mortality Risk from Co-Morbidities independent of Triple-Negative Breast Cancer Status: NCI SEER-based Cohort Analysis [O] . Helen Swede, Amna Sarwar, Anil Magge, -1

机译：独立于三阴性乳腺癌的合并症的死亡率风险：基于NCI SEER的队列分析
7. Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis [O] . Helen Swede, Amna Sarwar, Anil Magge, 2016

机译：来自同血症的死亡率风险独立于三阴性乳腺癌地位：基于NCI-Seer的群组分析

Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis.

摘要

著录项

相似文献

相关主题

期刊订阅